Delivery Order SPE2DB20D2104-SPE2DB24FS60Z
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,675.38, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 8, 2025. The contract is not associated with any set-aside designation. AmerisourceBergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,133.31, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,059.73, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 17, 2024. The contract is not designated with a set-aside requirement, indicating open...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,209.46, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. This award is not associated with a set-aside designation. AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,679.34, is for the provision of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract has a completion date of December 19, 2024 and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation associated with...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,245.64, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract has a firm fixed price pricing type and is a delivery order with a completion date of January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,187.40, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 9, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,035.96, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 14, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a larger...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,410.77, is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. The award has an ultimate completion date of May 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a $3,441.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty pharmaceutical product, with a period of performance through July 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS60ZDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,740.61, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, with a completion date of February 16, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation indicated for this award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 2/15/24 |